EyePoint files defamation lawsuit against Ocular Therapeutix over false statements about DURAVYU

EyePoint, Inc.

Complaint filed March 20, 2026 in Middlesex County Superior Court (Massachusetts).
Alleges Ocular Therapeutix made false/misleading representations about EyePoint's lead product DURAVYU (vorolanib intravitreal insert).
Claims include defamation, commercial disparagement, violation of Mass. Gen. L. c. 93A, and tortious interference.
Seeks injunctive relief, public retraction, monetary damages, attorneys' fees, and other relief.
EyePoint asserts defendant's actions harmed its business relations and clinical results reputation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.